This opened a can of worms I think.
I confess to knowing stuff all about Acadia.
Do they have a drug that they will need to use the voucher on?
Of course if they do then we receive 1/3 at market rates as per the agreement.
And should we receive $30 mil we can progress NNZ 2591
However, what about the flip side.
Can we get into bed with Acadia again, get them to fund the trials of NNZ 2591 and then use the voucher on it?
Surely we'd be a massive take over target if that were to occur.
And so would Acadia.
Ann: Commentary on potential benefit to Neuren of RPD designation, page-10
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$13.07 |
Change
0.220(1.71%) |
Mkt cap ! $1.635B | |||
| Open | High | Low | Value | Volume |
| $13.15 | $13.37 | $12.92 | $4.880M | 371.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 157 | $13.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.08 | 1355 | 10 |
View Market Depth
| Last trade - 13.16pm 18/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |